Fertility Biotech AG
Quick facts
Marketed products
- Gonal-f® RFF · Reproductive Medicine / Fertility
Gonal-f RFF is a recombinant human follicle-stimulating hormone (FSH) that stimulates the growth and maturation of ovarian follicles in women undergoing fertility treatment.
Phase 3 pipeline
- AFOLIA · Fertility / Reproductive Health
AFOLIA is a folate receptor alpha (FRα) antagonist designed to modulate immune responses and enhance fertility outcomes.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Fertility Biotech AG
What are Fertility Biotech AG's marketed drugs?
Top marketed products include Gonal-f® RFF.
What is Fertility Biotech AG's pipeline?
Fertility Biotech AG has 1 drugs in Phase 3, 0 in Phase 2, 1 in Phase 1. Late-stage candidates include AFOLIA.
Related
- Gonal-f® RFF · Reproductive Medicine / Fertility
- Sector hub: All tracked pharma companies